Low pre-existing endemic human coronavirus (HCoV-NL63)-specific T cell frequencies are associated with impaired SARS-CoV-2-specific T cell responses in people living with HIV

被引:1
|
作者
Ng'uni, Tiza L. [1 ]
Musale, Vernon [2 ,3 ]
Nkosi, Thandeka [1 ]
Mandolo, Jonathan [4 ]
Mvula, Memory [4 ]
Michelo, Clive [2 ,3 ]
Karim, Farina [1 ]
Moosa, Mohomed Yunus S. [5 ]
Khan, Khadija [1 ]
Jambo, Kondwani Charles [4 ,6 ]
Hanekom, Willem [1 ,7 ]
Sigal, Alex [1 ]
Kilembe, William [2 ,3 ]
Ndhlovu, Zaza M. [1 ,5 ,8 ,9 ]
机构
[1] Africa Hlth Res Inst AHRI, Nelson R Mandela Sch Med, Durban, South Africa
[2] Emory Univ Georgia, Ctr Excellence Influenza Res & Surveillance CEIRS, Lusaka, Zambia
[3] Ctr Family Hlth Res Zambia CFHRZ, Zambia Emory HIV Res Project ZEHRP, Lusaka, Zambia
[4] Infect & Immun Res Grp, Malawi Liverpool Wellcome Trust Clin Res Programme, Blantyre, Malawi
[5] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Human Immunodeficiency Virus HIV Pathogenesis Prog, Durban, South Africa
[6] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, England
[7] UCL, Div Infect & Immun, London, England
[8] Ragon Inst Massachusetts Gen Hosp MGH, Massachusetts Inst Technol MIT, Cambridge, MA 02139 USA
[9] Harvard Univ, Cambridge, MA 02138 USA
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 14卷
基金
英国惠康基金; 美国国家卫生研究院;
关键词
HIV; SARS-CoV-2; HCoV-NL63; COVID-19; T-cell response; antibody response; ANTIBODIES;
D O I
10.3389/fimmu.2023.1291048
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Understanding how HIV affects SARS-CoV-2 immunity is crucial for managing COVID-19 in sub-Saharan populations due to frequent coinfections. Our previous research showed that unsuppressed HIV is associated with weaker immune responses to SARS-CoV-2, but the underlying mechanisms are unclear. We investigated how pre-existing T cell immunity against an endemic human coronavirus HCoV-NL63 impacts SARS-CoV-2 T cell responses in people living with HIV (PLWH) compared to uninfected individuals, and how HIV-related T cell dysfunction influences responses to SARS-CoV-2 variants.Methods We used flow cytometry to measure T cell responses following PBMC stimulation with peptide pools representing beta, delta, wild-type, and HCoV-NL63 spike proteins. Luminex bead assay was used to measure circulating plasma chemokine and cytokine levels. ELISA and MSD V-PLEX COVID-19 Serology and ACE2 Neutralization assays were used to measure humoral responses.Results Regardless of HIV status, we found a strong positive correlation between responses to HCoV-NL63 and SARS-CoV-2. However, PLWH exhibited weaker CD4+ T cell responses to both HCoV-NL63 and SARS-CoV-2 than HIV-uninfected individuals. PLWH also had higher proportions of functionally exhausted (PD-1high) CD4+ T cells producing fewer proinflammatory cytokines (IFN gamma and TNF alpha) and had elevated plasma IL-2 and IL-12(p70) levels compared to HIV-uninfected individuals. HIV status didn't significantly affect IgG antibody levels against SARS-CoV-2 antigens or ACE2 binding inhibition activity.Conclusion Our results indicate that the decrease in SARS-CoV-2 specific T cell responses in PLWH may be attributable to reduced frequencies of pre-existing cross-reactive responses. However, HIV infection minimally affected the quality and magnitude of humoral responses, and this could explain why the risk of severe COVID-19 in PLWH is highly heterogeneous.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2-specific memory T cell responses
    Ramirez, Sydney I.
    Grifoni, Alba
    Weiskopf, Daniela
    Parikh, Urvi M.
    Heaps, Amy
    Faraji, Farhoud
    Sieg, Scott F.
    Ritz, Justin
    Moser, Carlee
    Eron, Joseph J.
    Currier, Judith S.
    Klekotka, Paul
    Sette, Alessandro
    Wohl, David A.
    Daar, Eric S.
    Hughes, Michael D.
    Chew, Kara W.
    Smith, Davey M.
    Crotty, Shane
    JCI INSIGHT, 2022, 7 (24)
  • [32] Weak SARS-CoV-2-specific responses of TIGIT-expressing CD8+T cells in people living with HIV after a third dose of a SARS-CoV-2 inactivated vaccine
    Jin Junyan
    Wang Xiuwen
    Li Yongzheng
    Yang Xiaodong
    Wang Hu
    Han Xiaoxu
    Sun Jin
    Ma Zhenglai
    Duan Junyi
    Zhang Guanghui
    Huang Tao
    Zhang Tong
    Wu Hao
    Zhang Xin
    Su Bin
    中华医学杂志英文版, 2023, 136 (24)
  • [33] Evaluation of SARS-COV-2-specific T cell responses in COVID-19 patients and non-infected controls
    Todorova, Yana
    Emilova, Radoslava
    Kuychukova, Nikol
    Grozdeva, Rusina
    Baymakova, Magdalena
    Yancheva, Nina
    Popov, Georgi
    Grifoni, Alba
    Weisscopf, Daniela
    Sete, Alessandro
    Nikolova, Maria
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 269 - 269
  • [34] Impaired SARS-CoV-2-specific T-cell reactivity in patients with cirrhosis following mRNA COVID-19 vaccination
    Al-Dury, Samer
    Waern, Johan
    Waldenstroem, Jesper
    Alavanja, Marko
    Saed, Hevar Hamah
    Toernell, Andreas
    Arabpour, Mohammad
    Wiktorin, Hanna Grauers
    Einarsdottir, Sigrun
    Ringlander, Johan
    Ringstroem, Gisela
    Hellstrand, Kristoffer
    Martner, Anna
    Lagging, Martin
    JHEP REPORTS, 2022, 4 (07)
  • [35] Inactivated SARS-CoV-2 vaccines elicit immunogenicity and T-cell responses in people living with HIV
    Lv, Zhengchao
    Li, Qin
    Feng, Zaixiong
    Zheng, Xi
    Yin, Na
    Yang, Haihao
    Gu, Qianlan
    Ying, Sai
    Qi, Yan
    Li, Xiaosi
    Wu, Runfang
    Wu, Zhao
    Yu, Xiyu
    Zou, Nanting
    Qin, Dongdong
    Wan, Chunping
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 102
  • [36] Dynamic SARS-CoV-2-specific B-cell and T-cell responses following immunization with an inactivated COVID-19 vaccine
    Chen, Yuxin
    Yin, Shengxia
    Tong, Xin
    Tao, Yue
    Ni, Jun
    Pan, Jie
    Li, Ming
    Wan, Yawen
    Mao, Minxin
    Xiong, Yali
    Yan, Xiaomin
    Yang, Yue
    Huang, Rui
    Wu, Chao
    Shen, Han
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (03) : 410 - 418
  • [37] Limited induction of SARS-CoV-2-specific T cell responses in children with multisystem inflammatory syndrome compared with COVID-19
    Singh, Vidisha
    Obregon-Perko, Veronica
    Lapp, Stacey A.
    Horner, Anna Marie
    Brooks, Alyssa
    Macoy, Lisa
    Hussaini, Laila
    Lu, Austin
    Gibson, Theda
    Silvestri, Guido
    Grifoni, Alba
    Weiskopf, Daniela
    Sette, Alessandro
    Anderson, Evan J.
    Rostad, Christina A.
    Chahroudi, Ann
    JCI INSIGHT, 2022, 7 (04)
  • [38] Divergent SARS-CoV-2-specific T- and B-cell responses in severe but not mild COVID-19 patients
    Oja, Anna E.
    Saris, Anno
    Ghandour, Cherien A.
    Kragten, Natasja A. M.
    Hogema, Boris M.
    Nossent, Esther J.
    Heunks, Leo M. A.
    Cuvalay, Susan
    Slot, Ed
    Linty, Federica
    Swaneveld, Francis H.
    Vrielink, Hans
    Vidarsson, Gestur
    Rispens, Theo
    van der Schoot, Ellen
    van Lier, Rene A. W.
    Ten Brinke, Anja
    Hombrink, Pleun
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2020, 50 (12) : 1998 - 2012
  • [39] Pre-existing T cell-mediated cross-reactivity to SARS-CoV-2 cannot solely be explained by prior exposure to endemic human coronaviruses
    Tan, Cedric C. S.
    Owen, Christopher J.
    Tham, Christine Y. L.
    Bertoletti, Antonio
    van Dorp, Lucy
    Balloux, Francois
    INFECTION GENETICS AND EVOLUTION, 2021, 95
  • [40] Impact of Previous Common Human Coronavirus Exposure on SARS-CoV-2-Specific T-Cell and Memory B-Cell Response after mRNA-Based Vaccination
    Casado, Jose L.
    Vizcarra, Pilar
    Martin-Hondarza, Adrian
    Blasco, Magdalena
    Grandal-Platero, Marta
    Haemmerle, Johannes
    Fernandez-Escribano, Marina
    Vallejo, Alejandro
    VIRUSES-BASEL, 2023, 15 (03):